Contrastingly, Alehan et al. highlighted an increased prevalence of positive serum CD in the migraine headache study group: total IgA and anti-tTG IgA were dosed, and serum CD antibodies were found positive (5.5% against 0.6% in the control group, p = 0.043) [25]. Here, CD79A is linked to Headache.